Found 30 matching trials
Allo HSCT Using RIC for Hematological Diseases PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation PHASE1 Background:
Blood cancers (such as leukemias or lymphomas) often do not re...
Show More Learn More & Join Trial
Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies NA The purpose of this study is to determine disease-free survival, overall su...
Show More Location
Dartmouth-Hitchcock Medical Center
Learn More & Join Trial
Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors NA Stem cells collected from sibling donors for allogenic transplants contain ...
Show More Status
Active Not Recruiting
Location
University of Alabama Hospital
Learn More & Join Trial
Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies PHASE1 Determine the safety and tolerability of POL6326 when used as a single mobi...
Show More Location
University of Kansas Cancer Center
Learn More & Join Trial
Therapy for Children With Advanced Stage Neuroblastoma PHASE2 Neuroblastoma is the most common extracranial solid tumor in childhood, wit...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency PHASE2 Background:
-DOCK8 deficiency is a genetic disorder that affects the immun...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer PHASE1 RATIONALE: Giving low doses of chemotherapy and total-body irradiation befo...
Show More Location
Multiple Locations
Learn More & Join Trial
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy PHASE2 The purpose of this study is to determine whether the use of lower doses of...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide PHASE2 This is a prospective, multi-center, Phase II study of hematopoietic cell t...
Show More Status
Active Not Recruiting
Location
City of Hope National Medical Center
Learn More & Join Trial